A Study of CT0596 in Plasma Cell Leukemia

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

NCT04923919 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

NCT05239689 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05822037 ·Status: RECRUITING ·Phase: NA

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

NCT05309213 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Multicenter Study of CAR-T Cells in Primary Ph+All

NCT07252336 ·Status: RECRUITING ·Phase: PHASE2

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

NCT04689659 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

NCT03796390 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies

NCT05654038 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL

NCT05639179 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

CAR-T Cells in the Treatment of Malignant Hematological Tumors

NCT05619861 ·Status: UNKNOWN ·Phase: NA

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

NCT04938115 ·Status: COMPLETED ·Phase: NA

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

NCT05907603 ·Status: COMPLETED ·Phase: EARLY_PHASE1

CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

NCT02965092 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

NCT03064269 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies

NCT03999697 ·Status: UNKNOWN ·Phase: PHASE1

Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT04835519 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

NCT05480501 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia

NCT05032599 ·Status: TERMINATED ·Phase: PHASE1

Study of CT071 Injection in RRMM or PPCL

NCT05838131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects with Relapsed or Refractory Acute Myeloid Leukemia

NCT05266950 ·Status: WITHDRAWN ·Phase: PHASE1

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

NCT06633354 ·Status: RECRUITING ·Phase: EARLY_PHASE1

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

NCT03984968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

NCT06911710 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

NCT03599375 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04546906 ·Status: UNKNOWN ·Phase: NA